Oncology Value Watchdog Report: ASH 2015 Highlights and Survey Results

Christina Corridon

  ( /-/media/files/publications/public/oncology-value-watchdog-report-ash-2015-highlights-and-survey-results.pdf?la=en )

> Download ( /-/media/files/publications/public/oncology-value-watchdog-report-ash-2015-highlights-and-survey-results.pdf?la=en )

This issue of the ZS Oncology Value Watchdog Report summarizes discussions about value that took place at the 2015 ASH conference. It also includes data from the ZS Value and Oncology Practice Management survey of MDs.

About the Expert

Christina Corridon is an Associate Principal in the Boston office and a leader in the ZS Oncology Practice. She has over a decade experience working in the pharmaceutical and biotech industries, with specific expertise in oncology and biosimilars. During her consulting career she has worked on US and global projects spanning commercialization strategy including launch strategy and planning, go-to market strategy, commercial models, marketing strategy and brand planning. Christina has an MPH in Health Policy and Management from the UCLA Fielding School of Public Health and an MBA from the Stern School of Business at New York University focused in Marketing. Christina completed her BA at Cornell University.